NOVARTIS NEORAL HYPERTENSION, RENAL FUNCTION EFFECTS IN RA PATIENTS SHOULD BE ASSESSED -- FDA CMTE.; POLYARTICULAR JUVENILE ARTHRITIS INDICATION RECOMMENDED
Executive Summary
The long-term effects of Novartis' Neoral (cyclosporine microemulsion) on blood pressure and renal function of rheumatoid arthritis patients should be assessed in post-marketing studies, FDA's Arthritis Drugs Advisory Committee recommended at its Feb. 4 meeting.